Search Within

Jaclyn Frances Hechtman

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (26)
Groups
  1. Epidemiology and Biostatistics (61)
  2. Department of Medicine (58)
  3. Solid Tumor Oncology Division (58)
  4. GSK Faculty (57)
  5. Human Oncology and Pathogenesis Program (53)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (52)

More Groups

People
  1. Nikolaus Schultz (47)
  2. David Solit (37)
  3. Michael Berger (32)
  4. Yelena Janjigian (24)
  5. Efsevia Vakiani (21)
  6. Walid Chatila (21)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (4)
  4. 2020 (6)
  5. 2019 (15)
  6. 2018 (11)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (11)
  3. Annals of Oncology (5)
  4. JCO Precision Oncology (4)
  5. Modern Pathology (4)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (13)
  3. Oxford University Press (6)
  4. Nature Publishing Group (4)
  5. Nature Research (4)
  6. American Medical Association (2)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • TRK fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations
    Journal Article

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion
    Journal Article

    Smith, J. J.; Chatila, W. K.; Sanchez-Vega, F.; Datta, J.; Connell, L. C.; Szeglin, B. C.; Basunia, A.; Boucher, T. M.; Hauser, H.; Wasserman, I.; more...
    Cancer Medicine (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save